Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 091 clinical trials in Amsterdam, The Netherlands across 13 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
The NetherlandsLong-term Study of Zanubrutinib for Patients with B-cell Blood Cancer
The NetherlandsStudy on Nivolumab and Ipilimumab for Patients with Untreated Unresectable or Metastatic Urothelial Cancer
The NetherlandsStudy to Identify Unknown Primary Cancer Using [18F]-AlF-FAPI-74 PET-CT for Patients with Carcinoma of Unknown Primary
The NetherlandsStudy of SAR443579 Infusion for Adults and Children with Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia, HR-MDS, or BPDCN
The NetherlandsLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
The NetherlandsStudy on RYZ101 for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors After Previous Treatment
The NetherlandsStudy of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer
The NetherlandsStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
The NetherlandsStudy of Olaparib for Patients with Advanced BRCA-Mutated Ovarian Cancer After Initial Platinum-Based Chemotherapy
The NetherlandsStudy on Rivaroxaban for Patients with Atrial Fibrillation and Coronary Artery Disease After Heart Procedure
The NetherlandsStudy of LN-145 (tumor infiltrating lymphocytes) with cyclophosphamide, fludarabine, and aldesleukin in patients with recurrent, metastatic, or persistent cervical cancer
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on colorectal cancer, bladder cancer, and gastric cancer treatments. Studies include novel combination therapies and immunological approaches to improve patient outcomes.
Research includes evaluation of new drug combinations and targeted therapies for various cancer types.
Groundbreaking research into Alzheimer's Disease and inflammatory polyneuropathy, focusing on early detection and treatment effectiveness. Studies include innovative biomarker research and twin-based investigations.
Emphasis on understanding disease progression and developing new therapeutic approaches.
Studies examining HPV prevention, mpox vaccination, and various immune-related conditions. Research includes vaccine effectiveness and novel treatment approaches for chronic conditions.
Focus on preventive measures and treatment optimization for infectious diseases.
Research involving eye conditions, dermatological treatments, and gastrointestinal disorders. Studies range from prosthetic eye care to innovative treatments for chronic conditions.
Investigating new therapeutic approaches for various specialized medical conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
